Key result
Statins remain safe and effective for primary prevention guided by absolute cardiovascular risk.
Why the study?
The status of LDL cholesterol as a primary target in ASCVD and the role of statins in primary prevention require updated synthesis of benefits and limitations.
Statins remain the foundational therapy for primary cardiovascular prevention due to their established efficacy in reducing ASCVD risk, safety profile, and low cost.
Answers are grounded in this paper and cite their sources.
May guide statin dosing and combinations in primary prevention; leaves open optimal patient selection and risk-benefit refinement.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Timo E. Strandberg (2022) conducted a review in Atherosclerotic cardiovascular disease (primary prevention). Statins was evaluated. Statins are effective and generally safe for primary cardiovascular prevention, with treatment decisions guided by absolute risk assessment and ongoing trials evaluating benefits in older adults.
Synapse has enriched 10 related papers. Consider them for comparative context: